GlassScriptPhysician profile
Christopher Robert Martin
NPI 1538668108
$3,817.09
in general payments reported to CMS, 2019-2025
20 companies · $639 in 2025
The $639 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $403 · 2022: $727 · 2023: $1,920 · 2024: $128 · 2025: $639.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,458 · Travel and Lodging: $1,229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,457.59 |
| Travel and Lodging | $1,229.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $853.15 | 2021-2024 | Lithoclast, Advance Xp, Rezum Generator |
| Cook Incorporated | $838.44 | 2023 | Fiber Dust |
| Cook Medical LLC | $462.29 | 2023 | Cook |
| Coloplast Corp | $340.08 | 2021-2023 | Titan |
| Teleflex LLC | $265.64 | 2021-2023 | Urolift |
| Pfizer INC. | $165.25 | 2024-2025 | |
| Janssen Scientific Affairs, LLC | $129.14 | 2025 | Erleada |
| Bayer Healthcare Pharmaceuticals INC. | $128.37 | 2023 | |
| Ethicon US, LLC | $104.30 | 2025 | Evarrest, Vistaseal, Ethicon |
| Astellas Pharma US INC | $102.91 | 2022-2025 | Xtandi |
| Olympus America INC. | $78.79 | 2022 | |
| Sumitomo Pharma America, INC. | $70.07 | 2024-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $65.56 | 2024-2025 | Erleada |
| Abbvie INC. | $42.18 | 2025 | |
| Procept Biorobotics Corporation | $38.49 | 2021-2024 | Aquabeam System |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Immunitybio, INC. | $34.99 | 2025 | |
| 180 Medical, INC. | $30.28 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $28.37 | 2025 | Bard Urinary Drainage Bag |
| Medtronic, INC. | $25.00 | 2023 | Interstim |
| Pacira Pharmaceuticals Incorporated | $13.79 | 2025 | Exparel, Iovera |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.